Publicaciones en colaboración con investigadores/as de Imperial College London (11)

2023

  1. A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

    Nature Medicine, Vol. 29, Núm. 7, pp. 1867-1876

  2. Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy

    Kidney International Reports, Vol. 8, Núm. 12, pp. 2754-2764

  3. Glomerular diseases in pregnancy: pragmatic recommendations for clinical management

    Kidney International, Vol. 103, Núm. 2, pp. 264-281

2022

  1. Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression

    Journal of the American Society of Nephrology : JASN, Vol. 33, Núm. 2, pp. 291-303

  2. Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy

    Journal of the American Society of Nephrology : JASN, Vol. 33, Núm. 6, pp. 1137-1153

2021

  1. Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy

    Journal of the American Society of Nephrology, Vol. 32, Núm. 2

2020

  1. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 35, Núm. 6, pp. 1002-1009

2019

  1. The role of complement in IgA nephropathy

    Molecular Immunology, Vol. 114, pp. 123-132

2012

  1. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

    Annals of the Rheumatic Diseases, Vol. 71, Núm. 11, pp. 1771-1782

  2. Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis

    Kidney International Supplements, Vol. 2, Núm. 2, pp. 139-274

2009

  1. European consensus statement on the terminology used in the management of lupus glomerulonephritis

    Lupus, Vol. 18, Núm. 3, pp. 257-263